Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 47.12 million | USD 1,335.11 million | 45% | 2023 |
The global AI in neurology operating room market size was worth around USD 47.12 million in 2023 and is predicted to grow to around USD 1,335.11 million by 2032 with a compound annual growth rate (CAGR) of roughly 45.00% between 2024 and 2032.
Artificial Intelligence (AI), one of the world’s most recent technological innovations with excellent future prospects, has the potential to revolutionize several aspects of treatment and diagnosis related to brain diseases. Neurology is a field of medicine that deals with the comprehensive care and treatment of diseases or conditions that involve the central nervous system (CNS) which comprises the spinal cord, the brain, and the peripheral nerves. AI in the neurology operating room represents using advanced artificial intelligence across stages involving neurological operations including postoperative care, intraoperative navigation, and preoperative planning. Some of the most common and currently used AI tools in the neurology operating room include surgical planning, epilepsy diagnosis, and brain mapping. However, the market is equipped to handle extended applications. As the need to develop more efficient and accurate neurological care is growing, the use of AI in neurology operating rooms is expected to grow. The global healthcare industry has shown excellent adoption of advanced technologies in recent times to deliver enhanced patient care starting from disease diagnosis to developing treatment plans and executing post-operative care resulting in higher demand for healthcare-oriented AI tools.
Rising number of patients with neurological conditions will drive the market demand
The global AI in neurology operating room market is expected to grow due to the growing number of patients with neurological conditions. Disorders that impact the brain, spinal cord, or the nerves found throughout the body are known as neurological conditions. The abnormalities can be related to either biochemical, structural, or electrical integrity of the brain, the spinal cord, or the peripheral nerves. Some of the most widely reported and well-researched neurological conditions are Alzheimer’s disease, acute spinal cord injury, Bell’s Palsy, Ataxia, Brain Tumors, and Amyotrophic Lateral Sclerosis (ALS). As per official statistics, more than 6.5 million people in the US over the age of 65 are currently living with Alzheimer’s disease. The most evident symptoms of the condition are a constant state of confusion and memory loss. It can lead to several behavioral changes such as aggression and difficulty with self-care. Factors such as age-induced changes in the brain, environmental or lifestyle reasons, and genetic elements can cause the disease. In addition to this, a relevantly new form of medical disorder has emerged in the healthcare industry under the name of functional neurologic conditions. It defines symptoms related to the nervous system that otherwise cannot be defined by neurological disease. This has led to an increased demand for more efficient handling of neurological conditions and AI can help meet the current requirements of the healthcare industry.
In the last decade, more investments have been directed toward the study of the human brain, its activity, and the effect of external conditions on its functioning. In May 2023, Neuralink, owned by Tesla head Elon Musk, announced the US Food and Drug Administration (FDA) approval of the first-in-human clinical trial for studying brain implants. In January 2022, Cleveland Clinic launched the first-of-its-kind brain study for the diagnosis and prevention of neurological disorders before the symptoms arrive thus providing growth scope for the global AI in neurology operating room market.
Concerns over privacy of patient’s confidential health-related and personal information may restrict the market expansion rate
The global industry for AI in neurology operating rooms is expected to be restricted due to concerns over access to private information related to patient's health and personal information. AI tools are trained using large data inputs. Their performance is optimized as more relevant information is added to train the tool. However, several regions across the globe are regulated by protocols and laws meant to protect citizen’s fundamental right to privacy. For instance, European regions are regulated by the General Data Protection Regulation (GDPR) thus acting as a significant growth barrier to the adoption of AI for healthcare purposes.
Increasing development in neurology-oriented AI will expand growth horizons
The global AI in the neurology operating room market is projected to come across new growth avenues as there is a rising rate of technological development to align Artificial Intelligence and the treatment of neurological conditions. For instance, in October 2023, BeCareLink announced the launch of a new application enabled by AI that can be used for generic neurologic exams for monitoring and screening neurological diseases. The company has also announced that it will soon be developing more applications for patients who have been diagnosed with Parkinson’s disease and traumatic brain injury. Extensive research suggests that AI will allow more safer brain surgery in the coming two years. This goal can be further achieved as more governments are allowing the healthcare sector to experiment with advanced tools such as AI by providing them with fresh grants and other forms of monetary or nonmonetary support.
Growing use of AI to train medical professionals in operating theaters holds high growth potential
The last few years have witnessed a steady rise in the use of virtual reality (VR) and augmented reality (AR) in the healthcare sector. Artificial Intelligence allows medical professionals to undertake practical training using AI-powered simulation before conducting the actual surgery or operation. This helps to eliminate risks during surgical procedures. Moreover, these simulations can be used to practice the surgical process multiple times until the neurosurgeons and other associated medical professionals are completely confident. AI-simulation training programs have high growth opportunities for the global AI in the neurology operating room market.
Legal and ethical considerations could challenge the market growth rate
The global industry for AI in neurology is projected to be challenged by the legal and ethical considerations that arise when using AI during surgical processes. For instance, AI-driven decisions cannot override decisions made by medical professionals, especially in sensitive cases such as end-of-life care and recommendations for treatment.
The global AI in neurology operating room market is segmented based on technology, component, application, and region.
Based on technology, the global market segments are machine learning & deep learning, natural language processing, and others. In 2023, the highest demand was observed in the machine learning & deep learning segment. It dominated nearly 38.02% of the segmental share since these technologies are used for processes such as pattern identification, neuroimaging data, and predicting outcomes. Deep learning is highly efficient in tasks related to image recognition.
Based on components, the global AI in the neurology operating room industry is divided into hardware and software-as-a-service.
Based on application, the global market divisions are diagnosis, training, outcome prediction & risk analysis, surgical planning & rehabilitation, and others. During 2023, the surgical planning & rehabilitation segment continued to dominate the segment. It secured more than 37.8% of the total share. The primary role of AI in the surgical planning & rehabilitation segment includes tissue differentiation and real-time navigation. Further, it also helps with reducing the risk associated with surgery and improving patient outcomes.
Report Attributes | Report Details |
---|---|
Report Name | AI in Neurology Operating Room Market |
Market Size in 2023 | USD 47.12 Million |
Market Forecast in 2032 | USD 1,335.11 Million |
Growth Rate | CAGR of 45.00% |
Number of Pages | 219 |
Key Companies Covered | Neurolink Innovations, Neurobotics, Synaptic Surgery, MindSurgical AI, BrainWave Surgical, NeuraSurgix, NeuroAI Surgical, NeuroAI Tech, Neurologix AI, CerebralAI Systems, AI NeuroOps, SynapTech Neuro, NeuroTech Solutions, NeuroSense AI, Cortex Medical AI., and others. |
Segments Covered | By Technology, By Component, By Application, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America will lead the market growth rate during the projection period
The global AI in neurology operating room market will be led by North America during the forecast period. It dominated nearly 42% of the total market share. The presence of a large number of patients with neurological conditions as well as a higher awareness rate about treatment options is driving the regional market revenue. Moreover, the US is one of the leading developers of AI technology and the region’s healthcare industry has been one of the first few sectors to adopt the latest technologies for enhanced patient care. A large concentration of companies pioneering AI technology and its application across sectors has been influential in opening the door for AI in neurological surgery in North America.
Europe is projected to generate high revenue led by the growing patient rate in the country along with technological innovations surrounding AI for healthcare. In 2023, researchers at the Center for Molecular Medicine at UMC Utrecht, a Netherlands-based hospital, developed a new AI tool called Sturgeon. It will help surgeons make critical decisions during surgeries related to brain tumors. Asia-Pacific is projected to witness significant revenue. China, Japan, and India will lead the regional market share.
The global AI in neurology operating room market is led by players like:
By Technology
By Component
By Application
FrequentlyAsked Questions
Artificial Intelligence (AI), one of the world’s most recent technological innovations with excellent future prospects, has the potential to revolutionize several aspects of treatment and diagnosis related to brain diseases.
The global AI in neurology operating room market is expected to grow due to the growing number of patients with neurological conditions.
According to study, the global AI in neurology operating room market size was worth around USD 47.12 million in 2023 and is predicted to grow to around USD 1,335.11 million by 2032.
The CAGR value of AI in neurology operating room market is expected to be around 45.00% during 2024-2032.
The global AI in neurology operating room market will be led by North America during the forecast period.
The global AI in neurology operating room market is led by players like Neurolink Innovations, Neurobotics, Synaptic Surgery, MindSurgical AI, BrainWave Surgical, NeuraSurgix, NeuroAI Surgical, NeuroAI Tech, Neurologix AI, CerebralAI Systems, AI NeuroOps, SynapTech Neuro, NeuroTech Solutions, NeuroSense AI and Cortex Medical AI.
The report explores crucial aspects of the AI in neurology operating room market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed